EP2806892
Samsett notkun mótefna og endóglýkósíðasa í meðferð
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
25.1.2013EP published:
6.3.2019EP application number:
13701871.9
EP translation filed:
6.6.2019Grant published:
15.7.2019EPO information:
European Patent Register
Max expiry date:
24.1.2033Expiry date:
24.1.2024
Title:
COMBINED THERAPEUTIC USE OF ANTIBODIES AND ENDOGLYCOSIDASES
Timeline
Today
25.1.2013EP application
6.3.2019EP Publication
6.6.2019Translation submitted
15.7.2019Registration published
24.1.2024Expires
Owner
Name:
Hansa Biopharma LimitedAddress:
Mount Manor House, 16 the Mount, Guildford, GU2 4HN, Surrey, England, GB
Inventor
Name:
CRISPIN, Matthew David MaxAddress:
Cheltenham GL52 6UE, GB
Name:
SCANLAN, Christopher NeilAddress:
deceased, GB
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201201314Date:
26.1.2012Country:
GB
Classification
Categories:
A61K 39/395, C12N 9/24, C07K 16/32
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 10.12.2019
Expires: 24.1.2021
Payer: Árnason Faktor
Number: 9
Paid: 15.12.2020
Expires: 24.1.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.12.2021
Expires: 24.1.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 13.12.2022
Expires: 24.1.2024
Payer: Árnason Faktor ehf.